---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-003270"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2023-02-01T23:59:59+00:00"
generated_at: "2026-06-20T03:57:12.613944+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ensysce declares Series A Preferred dividend with 1,000 votes per 0.001 share, tied to reverse split vote

## Summary
- Board declares dividend of 0.001 Series A Preferred share per common share; record date Feb 13, 2023.
- Each 0.001 of a share carries 1,000 votes; voting limited exclusively to reverse split and adjournment proposals.
- Preferred shares are non-transferable except with common; automatically redeemed if not voted at the meeting.
- Liquidation preference of $0.0001 per share; no dividend or conversion rights; filing of Certificate of Designation.

## SEC filing metadata
- accession: 0001493152-23-003270
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2023-02-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/0001493152-23-003270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-003270
- JSON: https://secwatch.observer/filing/0001493152-23-003270.json
- Plain text: https://secwatch.observer/filing/0001493152-23-003270.txt

## Key facts
- Governance Changes
  Ensysce Biosciences, Inc.: Creation of Series A Preferred Stock via a dividend declared on January 31, 2023, effective upon filing of a Certificate of Designation (effective 2023-01-31).
  - Change: charter amendment
  - Effective: 2023-01-31
  source text: On January 31, 2023, the Board of Directors (the “Board”) of Ensysce Biosciences Inc. (the “Company”) declared a dividend of 0.001 of a share of Series A Preferred Stock, par value $0.0001 per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) to stockholders of record at 5:00 pm Eastern Time on February 13, 2023 (the “Record Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716947/000149315223003270/0001493152-23-003270-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.